0001193125-21-206687.txt : 20210804 0001193125-21-206687.hdr.sgml : 20210804 20210701201701 ACCESSION NUMBER: 0001193125-21-206687 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20210701 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Royalty Pharma plc CENTRAL INDEX KEY: 0001802768 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 110 EAST 59TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 883-0200 MAIL ADDRESS: STREET 1: 110 EAST 59TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Royalty Pharma Holdings Ltd. CENTRAL INDEX KEY: 0001868134 IRS NUMBER: 981526515 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 110 EAST 59TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-883-0200 MAIL ADDRESS: STREET 1: 110 EAST 59TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 CORRESP 1 filename1.htm CORRESP

Royalty Pharma plc

110 East 59th Street

New York, New York 10022

July 1, 2021

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporate Finance

100 F Street, N.E.

Washington, DC 20549

 

Re:

  Royalty Pharma plc

  Registration Statement on Form S-4

  File No. 333-257188

  Acceleration Request

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Royalty Pharma plc (the “Company”), along with co-registrant, Royalty Pharma Holdings Ltd., hereby respectfully request that the effective date of the above referenced Registration Statement on Form S-4, filed by the Company on June 17, 2021 and amended on July 1, 2021, be accelerated to 9:00 a.m. (EDT) on July 7, 2021, or as soon thereafter as practicable.

Please call Richard D. Truesdell, Jr. of Davis Polk & Wardwell LLP at (212) 450-4674 with any questions.

 

Very truly yours,
ROYALTY PHARMA PLC
By:  

/s/ Pablo Legorreta

Name:   Pablo Legorreta
Title:   Chief Executive Officer

 

cc:

Richard D. Truesdell, Jr.

Davis Polk & Wardwell LLP